Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 13/20 | 0.60 |
| ▸ | CA2 | P00918 | 13/20 | 0.60 |
| ▸ | CA1 | P00915 | 12/20 | 0.60 |
| ▸ | CA12 | O43570 | 11/20 | 0.60 |
| ▸ | OGA | O60502 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25783041 | 1.00 | CA9 (0.60) | CA9CA2CA1CA12OGA | |
| SCHEMBL15247399 | 1.00 | CA9 (0.60) | CA9CA2CA1CA12OGA | |
| SCHEMBL12935270 | 1.00 | CA9 (0.60) | CA9CA2CA1CA12OGA | |
| SCHEMBL25721435 | 1.00 | CA9 (0.60) | CA9CA2CA1CA12OGA | |
| SCHEMBL13464528 | 1.00 | CA9 (0.60) | CA9CA2CA1CA12OGA | |
| SCHEMBL7146506 | 1.00 | CA9 (0.60) | CA9CA2CA1CA12OGA | |
| SCHEMBL2723141 | 1.00 | CA9 (0.60) | CA9CA2CA1CA12OGA | |
| SCHEMBL2736530 | 1.00 | CA9 (0.60) | CA9CA2CA1CA12OGA | |
| SCHEMBL18391019 | 1.00 | CA9 (0.60) | CA9CA2CA1CA12OGA | |
| SCHEMBL14923179 | 1.00 | CA9 (0.60) | CA9CA2CA1CA12OGA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 341 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12632323-B2 | Cloud-native application programming interface (API) recommendation method fusing data augmentation and contrastive learning | CHINA JILIANG UNIVERSITY (CN) | 2026-05-19 | — | — | US | claimed |
| EP-4569704-A1 | TECHNIQUES FOR TRANSMISSION CONFIGURATION INDICATOR (TCI) STATE INDICATION FOR COMPONENT CARRIERS IN DIFFERENT MODES | QUALCOMM INCORPORATED (US) | 2025-06-18 | — | — | EP | claimed |
| CN-119605118-A | Techniques for Transmit Configuration Indicator (TCI) status indication for component carriers in different modes | 高通股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119541892-A | System and method for evaluating breast cancer risk by using Mendelian randomization | 华中科技大学 | 2025-02-28 | — | — | CN | claimed |
| US-20250013514-A1 | CLOUD-NATIVE APPLICATION PROGRAMMING INTERFACE (API) RECOMMENDATION METHOD FUSING DATA AUGMENTATION AND CONTRASTIVE LEARNING | CHINA JILIANG UNIVERSITY (CN) | 2025-01-09 | — | — | US | claimed |
| US-20240401027-A1 | METHOD FOR IMPROVED INTRON TAGGING AND AUTOMATED CLONE RECOGNITION | PROXYGEN GMBH (AT) | 2024-12-05 | — | — | US | claimed |
| CN-118674909-A | Similar object identification method based on visual question-answering module and color mask | 华南理工大学 | 2024-09-20 | — | — | CN | claimed |
| EP-4408992-A1 | METHOD FOR IMPROVED INTRON TAGGING AND AUTOMATED CLONE RECOGNITION | Proxygen GmbH (AT) | 2024-08-07 | — | — | EP | claimed |
| CN-116741274-B | Method, device and medium for determining representative sequence in targeted sequencing data | 杭州联川基因诊断技术有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-118301604-A | Safe data sharing method based on blockchain unmanned aerial vehicle cooperation | 北京交通大学 | 2024-07-05 | — | — | CN | claimed |
| CN-116741274-A | Method, device and medium for determining representative sequence in targeted sequencing data | 杭州联川基因诊断技术有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-115831233-B | Targeted sequencing data preprocessing method, equipment and medium based on mTag | 杭州联川基因诊断技术有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-111522685-B | Distributed storage method and apparatus, server, and computer-readable storage medium | 中国南方电网有限责任公司 | 2023-05-12 | — | — | CN | claimed |
| US-11635960-B2 | Processing metadata, policies, and composite tags | THE CHARLES STARK DRAPER LABORATORY, INC. (US) | 2023-04-25 | — | — | US | claimed |
| WO-2023046996-A1 | METHOD FOR IMPROVED INTRON TAGGING AND AUTOMATED CLONE RECOGNITION | CEMM - FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GMBH (AT) | 2023-03-30 | — | — | WO | claimed |
| CN-115831233-A | mTag-based targeted sequencing data preprocessing method, equipment and medium | 杭州联川基因诊断技术有限公司 | 2023-03-21 | — | — | CN | claimed |
| US-20220378058-A1 | COMPOSITIONS COMPRISING SUBSETS OF MILK LIPIDS, AND METHODS FOR PRODUCING THE SAME | Perfect Day, Inc. | 2022-12-01 | — | — | US | claimed |
| CN-114929026-A | Compositions comprising a subset of milk lipids and methods of making the same | 完美日股份有限公司 | 2022-08-19 | — | — | CN | claimed |
| EP-4027797-A2 | COMPOSITIONS COMPRISING SUBSETS OF MILK LIPIDS, AND METHODS FOR PRODUCING THE SAME | Perfect Day, Inc. (US) | 2022-07-20 | — | — | EP | claimed |
| CN-111488693-B | Charging load simulation method for charging station considering number of day-average charging vehicles | 国网江苏省电力有限公司苏州供电分公司 | 2022-06-24 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12632323-B2 | Cloud-native application programming interface (API) recommendation method fusing data augmentation and contrastive learning | MAFG, MYB, IAPP | CA9 533/4885CA2 974/4885CA1 1591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.